Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
BEIJING VDJBIO CO., LTD. currently has 2 pending office actions. These matters involve 2 distinct examiners and 0 distinct art units. HAMA, JOANNE is the busiest examiner for the portfolio, with 1 busiest examiner pending office action.
The presence of 2 distinct examiners for 2 pending office actions indicates that the portfolio's current workload is fully distributed. Because there are 0 distinct art units listed, the prosecution is not currently categorized within a specific art unit structure in this data set. Practitioners should note that the busiest examiner is one of the 2 distinct examiners currently reviewing the company's applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAMA, JOANNE | 1 | 25.7% | +40.0% |
| BUTTICE, AUDREY L | 1 | 47.9% | +25.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686480 | FUSION PROTEIN OF INTERLEUKIN 2 AND APPLICATION THEREOF IN IBD | HAMA, JOANNE | — |
| 18686430 | FUSION PROTEIN OF INTERLEUKIN-2 AND APPLICATION THEREOF IN ALS | BUTTICE, AUDREY L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686480 | FUSION PROTEIN OF INTERLEUKIN 2 AND APPLICATION THEREOF IN IBD | HAMA, JOANNE | — |
| 18686430 | FUSION PROTEIN OF INTERLEUKIN-2 AND APPLICATION THEREOF IN ALS | BUTTICE, AUDREY L | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18686480 | FUSION PROTEIN OF INTERLEUKIN 2 AND APPLICATION THEREOF IN IBD | HAMA, JOANNE | — | §103§112Other | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18686430 | FUSION PROTEIN OF INTERLEUKIN-2 AND APPLICATION THEREOF IN ALS | BUTTICE, AUDREY L | — | §101§102§103§112DP | Non-Final OA | — | Pending | Feb 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial